These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 10695016

  • 1. [Gene therapy for inherited diseases using heamatopoietic stem cells--gene therapy for patients with chronic granulomatous disease].
    Nunoi H, Ishibashi F.
    Hum Cell; 1999 Sep; 12(3):103-8. PubMed ID: 10695016
    [Abstract] [Full Text] [Related]

  • 2. [Statistical evaluation of chronic granulomatous disease in Japan and basic studies for gene therapy for CGD patients].
    Nunoi H, Ishibashi F.
    Rinsho Byori; 1999 Jul; 47(7):658-64. PubMed ID: 10442045
    [Abstract] [Full Text] [Related]

  • 3. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
    Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T.
    J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
    [Abstract] [Full Text] [Related]

  • 4. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
    Roesler J, Brenner S, Bukovsky AA, Whiting-Theobald N, Dull T, Kelly M, Civin CI, Malech HL.
    Blood; 2002 Dec 15; 100(13):4381-90. PubMed ID: 12393624
    [Abstract] [Full Text] [Related]

  • 5. Chronic granulomatous disease: towards gene therapy.
    Thrasher A, Segal A, Casimir C.
    Immunodeficiency; 1993 Dec 15; 4(1-4):327-33. PubMed ID: 8167728
    [Abstract] [Full Text] [Related]

  • 6. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
    Becker S, Wasser S, Hauses M, Hossle JP, Ott MG, Dinauer MC, Ganser A, Hoelzer D, Seger R, Grez M.
    Hum Gene Ther; 1998 Jul 20; 9(11):1561-70. PubMed ID: 9694155
    [Abstract] [Full Text] [Related]

  • 7. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, Roos D, Verhoeven AJ.
    J Clin Invest; 1994 May 20; 93(5):2120-6. PubMed ID: 8182143
    [Abstract] [Full Text] [Related]

  • 8. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, Metin A, de Boer M, Avcılar H, Patıroğlu T, Yıldıran A, Yeğin O, Tezcan I, Sanal Ö, Roos D.
    J Allergy Clin Immunol; 2013 Nov 20; 132(5):1156-1163.e5. PubMed ID: 23910690
    [Abstract] [Full Text] [Related]

  • 9. Genetic and biochemical background of chronic granulomatous disease.
    Jurkowska M, Bernatowska E, Bal J.
    Arch Immunol Ther Exp (Warsz); 2004 Nov 20; 52(2):113-20. PubMed ID: 15179325
    [Abstract] [Full Text] [Related]

  • 10. [Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].
    Morel F.
    Bull Acad Natl Med; 2007 Feb 20; 191(2):377-90; discussion 390-2. PubMed ID: 17969555
    [Abstract] [Full Text] [Related]

  • 11. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A, Newburger PE.
    Arch Biochem Biophys; 1998 Dec 15; 360(2):158-64. PubMed ID: 9851826
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy for chronic granulomatous disease.
    Kang EM, Malech HL.
    Methods Enzymol; 2012 Dec 15; 507():125-54. PubMed ID: 22365772
    [Abstract] [Full Text] [Related]

  • 13. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
    Zentilin L, Tafuro S, Grassi G, Garcia R, Ventura A, Baralle F, Falaschi A, Giacca M.
    Exp Cell Res; 1996 Jun 15; 225(2):257-67. PubMed ID: 8660913
    [Abstract] [Full Text] [Related]

  • 14. Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
    Rappa G, Anzanello F, Alexeyev M, Fodstad O, Lorico A.
    Eur J Haematol; 2007 May 15; 78(5):440-8. PubMed ID: 17331133
    [Abstract] [Full Text] [Related]

  • 15. The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production.
    Bellantuono I, Lashford LS, Rafferty JA, Fairbairn LJ.
    Haematologica; 2000 May 15; 85(5):451-7. PubMed ID: 10800158
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
    Zentilin L, Tafuro S, Serra C, Falaschi A, Giacca M.
    Ann Ist Super Sanita; 1998 May 15; 34(4):447-55. PubMed ID: 10234875
    [Abstract] [Full Text] [Related]

  • 17. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.
    Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Lüthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M.
    Nat Med; 2006 Apr 15; 12(4):401-9. PubMed ID: 16582916
    [Abstract] [Full Text] [Related]

  • 18. A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression.
    Sokolic RA, Sekhsaria S, Sugimoto Y, Whiting-Theobald N, Linton GF, Li F, Gottesman MM, Malech HL.
    Blood; 1996 Jan 01; 87(1):42-50. PubMed ID: 8547675
    [Abstract] [Full Text] [Related]

  • 19. Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.
    Chiriaco M, Salfa I, Di Matteo G, Rossi P, Finocchi A.
    Pediatr Allergy Immunol; 2016 May 01; 27(3):242-53. PubMed ID: 26680691
    [Abstract] [Full Text] [Related]

  • 20. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.
    Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, Stasia MJ.
    Hum Genet; 2004 Oct 01; 115(5):418-27. PubMed ID: 15338276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.